IT1394570B1 - Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni. - Google Patents

Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.

Info

Publication number
IT1394570B1
IT1394570B1 ITMI2009A001171A ITMI20091171A IT1394570B1 IT 1394570 B1 IT1394570 B1 IT 1394570B1 IT MI2009A001171 A ITMI2009A001171 A IT MI2009A001171A IT MI20091171 A ITMI20091171 A IT MI20091171A IT 1394570 B1 IT1394570 B1 IT 1394570B1
Authority
IT
Italy
Prior art keywords
osteoartrosis
pathologies
taper
therapy
damage
Prior art date
Application number
ITMI2009A001171A
Other languages
English (en)
Inventor
Anna Maria Zanellato
Lanfranco Callegaro
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITMI2009A001171A priority Critical patent/IT1394570B1/it
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Priority to ES10729841T priority patent/ES2421300T3/es
Priority to CN201080026688.0A priority patent/CN102470190B/zh
Priority to SI201030230T priority patent/SI2448606T1/sl
Priority to EP10729841.6A priority patent/EP2448606B1/en
Priority to PL10729841T priority patent/PL2448606T3/pl
Priority to RU2012103465/15A priority patent/RU2529803C2/ru
Priority to SG2011084563A priority patent/SG176110A1/en
Priority to PCT/EP2010/059183 priority patent/WO2011000820A2/en
Priority to DK10729841.6T priority patent/DK2448606T3/da
Priority to MYPI2011006029A priority patent/MY155301A/en
Priority to CA2763945A priority patent/CA2763945C/en
Priority to PT107298416T priority patent/PT2448606E/pt
Priority to US13/380,971 priority patent/US8771672B2/en
Publication of ITMI20091171A1 publication Critical patent/ITMI20091171A1/it
Priority to HK12106123.3A priority patent/HK1165336A1/xx
Application granted granted Critical
Publication of IT1394570B1 publication Critical patent/IT1394570B1/it
Priority to HRP20130509AT priority patent/HRP20130509T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
ITMI2009A001171A 2009-07-02 2009-07-02 Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni. IT1394570B1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
ITMI2009A001171A IT1394570B1 (it) 2009-07-02 2009-07-02 Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
MYPI2011006029A MY155301A (en) 2009-07-02 2010-06-29 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders
SI201030230T SI2448606T1 (sl) 2009-07-02 2010-06-29 Biološki matrial primeren za zdravljenje osteoartroze, poškodb ligamentov in za zdravljenje sklepnih nepravilnosti
EP10729841.6A EP2448606B1 (en) 2009-07-02 2010-06-29 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders
PL10729841T PL2448606T3 (pl) 2009-07-02 2010-06-29 Materiał biologiczny odpowiedni do terapii choroby zwyrodnieniowej stawów, uszkodzenia więzadła i leczenia schorzeń stawów
RU2012103465/15A RU2529803C2 (ru) 2009-07-02 2010-06-29 Биологический материал, подходящий для терапии остеоартроза, повреждения связок и для лечения патологических состояний суставов
SG2011084563A SG176110A1 (en) 2009-07-02 2010-06-29 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders
PCT/EP2010/059183 WO2011000820A2 (en) 2009-07-02 2010-06-29 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders
ES10729841T ES2421300T3 (es) 2009-07-02 2010-06-29 Material biológico adecuado para la terapia de la osteoartrosis, el daño de ligamento y para el tratamiento de trastornos articulares
CN201080026688.0A CN102470190B (zh) 2009-07-02 2010-06-29 适用于治疗骨关节炎、韧带损伤和关节失调的生物材料
CA2763945A CA2763945C (en) 2009-07-02 2010-06-29 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders
PT107298416T PT2448606E (pt) 2009-07-02 2010-06-29 Material biológico apropriado para a terapia de osteoartrose, lesões de ligamentos e para o tratamento de distúrbios das articulações
US13/380,971 US8771672B2 (en) 2009-07-02 2010-06-29 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders
DK10729841.6T DK2448606T3 (da) 2009-07-02 2010-06-29 Biologisk materiale, som er egnet til terapi af osteoarthrosis, ligamentskader og behandling af ledsygdomme.
HK12106123.3A HK1165336A1 (en) 2009-07-02 2012-06-21 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders
HRP20130509AT HRP20130509T1 (hr) 2009-07-02 2013-06-10 Biološki materijal pogodan za lijeäśenje osteoartroze, povreda ligamenata i za lijeäśenje poremeä†aja zglobova

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A001171A IT1394570B1 (it) 2009-07-02 2009-07-02 Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.

Publications (2)

Publication Number Publication Date
ITMI20091171A1 ITMI20091171A1 (it) 2011-01-03
IT1394570B1 true IT1394570B1 (it) 2012-07-05

Family

ID=41716303

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A001171A IT1394570B1 (it) 2009-07-02 2009-07-02 Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.

Country Status (16)

Country Link
US (1) US8771672B2 (it)
EP (1) EP2448606B1 (it)
CN (1) CN102470190B (it)
CA (1) CA2763945C (it)
DK (1) DK2448606T3 (it)
ES (1) ES2421300T3 (it)
HK (1) HK1165336A1 (it)
HR (1) HRP20130509T1 (it)
IT (1) IT1394570B1 (it)
MY (1) MY155301A (it)
PL (1) PL2448606T3 (it)
PT (1) PT2448606E (it)
RU (1) RU2529803C2 (it)
SG (1) SG176110A1 (it)
SI (1) SI2448606T1 (it)
WO (1) WO2011000820A2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20130110A1 (it) * 2013-04-24 2014-10-25 Fidia Farmaceutici Composizioni farmaceutiche comprendenti acido ialuronico per il trattamento del black disc
CN103340904B (zh) * 2013-07-10 2016-03-23 西比曼生物科技（香港）有限公司 治疗骨关节炎的组合物
RU2565413C1 (ru) * 2014-04-22 2015-10-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный аграрный университет имени Н.И. Вавилова" Способ лечения остеоартроза у животных
TWI566774B (zh) * 2014-10-06 2017-01-21 佛教慈濟醫療財團法人花蓮慈濟醫院 治療關節疾病的組成物及其方法
CN105106238A (zh) * 2015-08-10 2015-12-02 山东省药学科学院 一种用于治疗骨关节炎和软骨缺损的细胞治疗组合物
US9861410B2 (en) 2016-05-06 2018-01-09 Medos International Sarl Methods, devices, and systems for blood flow
RU2624230C1 (ru) * 2016-07-13 2017-07-03 Федеральное государственное бюджетное учреждение "Приволжский федеральный медицинский исследовательский центр" Министерства здравоохранения Российской Федерации Способ лечения больных при острой стадии диабетической нейростеоартропатии по типу "стопа Шарко"
CN107550935A (zh) * 2017-09-11 2018-01-09 上海亚睿生物科技有限公司 一种治疗关节疾病的生物凝胶剂及其应用
CN108653329A (zh) * 2018-05-28 2018-10-16 广东唯泰生物科技有限公司 一种用于治疗骨关节炎的药物及其制备方法
RU2708376C1 (ru) * 2018-12-12 2019-12-06 Александр Сергеевич Тепляшин Биомедицинская композиция для лечения дегенеративных заболеваний суставов на основе региональных стволовых клеток взрослого организма
CN110237095A (zh) * 2019-05-28 2019-09-17 武汉汉密顿生物科技股份有限公司 用于治疗骨性关节炎软骨缺损的干细胞注射液及其制备和应用
IT201900009933A1 (it) 2019-06-24 2020-12-24 Fidia Farm Spa Composizioni farmaceutiche comprendenti derivati ammidici dell'acido ialuronico per uso nel trattamento di traumi ossei, in particolare in pazienti con problemi di osteopenia o osteoporosi

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1282207B1 (it) 1995-11-20 1998-03-16 Fidia Advanced Biopolymers Srl Sistemi di coltura di cellule staminali di midollo osseo umano in matrici tridimensionali costituiti da esteri dell'acido ialuronico
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
IL145002A0 (en) * 1999-03-10 2002-06-30 Univ Pittsburgh Adipose-derived stem cells and lattices
ITAL990010U1 (it) 1999-12-14 2001-06-14 Maria Cristina Sacchi Nuova metodica di laboratorio per preparare gel e membrane piastriniche ottenute dal concentrato piastrinico.
EP1276486B2 (en) * 2000-04-25 2014-03-05 Osiris Therapeutics, Inc. Joint repair using mesenchymal stem cells
CA2365376C (en) * 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
ATE414522T1 (de) * 2003-10-09 2008-12-15 Robert John Petrella Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
ITPD20050056A1 (it) * 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
JP2009531120A (ja) * 2006-03-31 2009-09-03 シーエスアイアール 軟組織のかさ増し
KR101457231B1 (ko) * 2006-04-19 2014-11-12 고쿠리츠 다이가쿠 호우징 나고야 다이가쿠 치주 연조직 재생용 조성물 및 그 제조 방법
CN100594029C (zh) * 2006-07-24 2010-03-17 凌沛学 一种关节腔内注射用药物组合物
US8034014B2 (en) * 2007-03-06 2011-10-11 Biomet Biologics, Llc Angiogenesis initation and growth
ES2333498B1 (es) * 2007-08-02 2011-01-10 Biotechnology Institute, I Mas D, S.L. Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.

Also Published As

Publication number Publication date
PL2448606T3 (pl) 2013-10-31
SI2448606T1 (sl) 2013-09-30
DK2448606T3 (da) 2013-08-05
SG176110A1 (en) 2011-12-29
CN102470190B (zh) 2015-09-02
ES2421300T3 (es) 2013-08-30
RU2012103465A (ru) 2013-08-10
EP2448606A2 (en) 2012-05-09
PT2448606E (pt) 2013-07-12
HRP20130509T1 (hr) 2013-08-31
US8771672B2 (en) 2014-07-08
WO2011000820A3 (en) 2011-04-07
CN102470190A (zh) 2012-05-23
CA2763945C (en) 2017-11-14
ITMI20091171A1 (it) 2011-01-03
HK1165336A1 (en) 2012-10-05
RU2529803C2 (ru) 2014-09-27
EP2448606B1 (en) 2013-05-15
US20120114609A1 (en) 2012-05-10
WO2011000820A2 (en) 2011-01-06
CA2763945A1 (en) 2011-01-06
MY155301A (en) 2015-09-30

Similar Documents

Publication Publication Date Title
IT1394570B1 (it) Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
EP2505136A4 (en) ELECTRODE DEVICE FOR MEASURING IMPEDANCE WITHIN THE HUMAN BODY, AND APPARATUS USING SUCH A DEVICE FOR MEASURING THE IMPEDANCE WITHIN THE HUMAN BODY AND CARRYING OUT A TREATMENT
ZA201901826B (en) Cell suspension for use in the treatment of lower extremity peripheral artery disease
BRPI1012129A2 (pt) enantiômeros de compostos spiro-oxindol e sua utilização como agentes terapêuticos.
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BR112012001344A2 (pt) derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças
BR112012012442A2 (pt) aparelhos para o tratamento de incontinência urinária de esforço e de urgência
SI2254870T1 (sl) 1-benzil-3-hidroksimetilindazolni derivati in njihova uporaba pri zdravljenju bolezni, ki temeljijo na ekspresiji MCP-1, CX3CR1
BR112012004836A2 (pt) pirazinilpiridinas úteis para o tratamento de doenças proliferativas
IL207278A0 (en) 1 - benzyl - 3 - hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp - 1, and cx3cr1
BRPI1010086A2 (pt) método e produtos para tratamento de doenças
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
BRPI0923377A2 (pt) Derivados de 1-amino-alquilciclohexano para o tratamento de doenças mediadas por mastócitos
DK2341900T3 (da) Lægemiddelprodukt og behandling
DK2859092T3 (da) Terapeutisk vaccine til behandling af diabetes type-1 hos børn, anvendelse af cellesorter og fremgangsmåde til at multiplicere treg-celler til fremstilling af terapeutisk vaccine til behandling af diabetes type-1
BRPI1010121A2 (pt) método de tratamento biológico
BR112012013591A2 (pt) dispositivo para tratamento eletroterapêutico
FR2950074B1 (fr) Equivalent de peau in vitro et procede de preparation
EP2654434A4 (en) METHOD FOR TREATING TISSUE DISEASES, TROUBLES AND INJURIES
IL216717A0 (en) USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
IT1398342B1 (it) Metodo e dispositivo di trattamento dell'acqua.
HK1172568A1 (en) Soluble pharmaceutical forms of n,n-diaminodiphenyl sulphone for optimum use in the treatment of various diseases nn-
ZA201005770B (en) The treatment of damaged skin
ES1070544Y (es) Dispositivo para la estimulacion de ubres en el proceso de ordeño
TH125076B (th) องค์ประกอบและวิธีการสำหรับการใช้เซลล์เพื่อการรักษาเนื้อเยื่อหัวใจ